Key Developments

In March 2024, Veeda Clinical Research Limited, a full-service contract research organization (CRO) with a proven record of drug development success, announced that it had acquired Heads, a privately-held European CRO which specializes in conducting clinical trials in oncology. Through this acquisition, Veeda Clinical Research Limited entered the league of global CROs with integrated capabilities to extend contract research services from discovery to clinical development extending to post commercial launch.
In November 2023, Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, announced the launch of Ichor Clinical Trial Services. Ichor Clinical offers a spectrum of customized clinical trial solutions, ranging from individual service options to full CRO assistance.
In September 2023, Parexel International Corporation, a contract research organization (CRO), and Partex, a data-to-drugs pharma platform, announced a partnership aiming to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and the development for biopharmaceutical customers worldwide and de-risk the assets in their portfolios. Under the partnership, Partex’s clinical trial execution by the Partex group of companies will be managed by Parexel as the preferred CRO provider. The organizations will also collaborate on improving clinical trial execution for customers through the Partex-validated artificial intelligence (AI) platform, adding to and expanding Parexel’s existing AI tools and capabilities.
In July, 2023, NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced its acquisition of CRI – The Clinical Research Institute, a Germany-based full service CRO. Combining the expertise of both organizations will position them as the leading MedTech CRO specializing in cardiovascular research services worldwide.
In December 2021, IQVIA INC., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, launched new research nursing and phlebotomy services to offer access to a global network of high-quality, credentialed professionals for patients participating in clinical trials. The IQVIA research nursing and phlebotomy teams possess the capability to conduct a diverse range of assessments, collect data and specimens, and provide assistance in the direct delivery and administration of investigational products to patients.